Figure 3From: Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trialsPercentage of patients with relapses during the 21 days observation period. Relapses in carrageenan and placebo treated groups presented in ITT and PP population. (* p < 0.05; ** p < 0.01).Back to article page